Skip to content

Efficacy and Safety of TORS for SCCA

A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01819480
Enrollment
110
Registered
2013-03-27
Start date
2013-03-31
Completion date
2025-12-31
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal Squamous Cell Carcinoma, Supraglottic Squamous Cell Carcinoma

Keywords

Surgery, Robotic, Carcinoma, squamous cell of head and neck

Brief summary

The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.

Interventions

Transoral robotic surgery using the daVinci robot to remove primary tumor

Sponsors

Katherine L Fedder
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult male or female * Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma

Exclusion criteria

* Metastatic disease

Design outcomes

Primary

MeasureTime frameDescription
Progression-free survival3 yearsDuration of time from date of surgery to date of recurrence or death

Secondary

MeasureTime frameDescription
Disease specific survival3 yearsDuration of time from the date of surgery until death with disease present

Other

MeasureTime frameDescription
Overall survival3 yearsMeasured from the date of surgery until date of death from any cause
Functional quality of life3 yearsSubject-reported functional outcome questionnaires will be used to quantify patient-reported speech and swallowing function
Incidence of adverse events3 yearsAdverse events occuring following the surgery will be reported and graded using CTCAE v4.0 criteria

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026